Cheol Kyu Oh

ORCID: 0000-0002-0497-6057
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Urinary Bladder and Prostate Research
  • Prostate Cancer Diagnosis and Treatment
  • Urological Disorders and Treatments
  • Minimally Invasive Surgical Techniques
  • Renal and Vascular Pathologies
  • Urologic and reproductive health conditions
  • Pediatric Urology and Nephrology Studies
  • Renal and related cancers
  • Bladder and Urothelial Cancer Treatments
  • Ureteral procedures and complications
  • Urinary Tract Infections Management
  • Prostate Cancer Treatment and Research
  • Pelvic floor disorders treatments
  • Organ Donation and Transplantation
  • Hormonal and reproductive studies
  • Urinary and Genital Oncology Studies
  • Kidney Stones and Urolithiasis Treatments
  • Sexual Differentiation and Disorders
  • Adrenal and Paraganglionic Tumors
  • Gastrointestinal Tumor Research and Treatment
  • Hormonal Regulation and Hypertension
  • Esophageal Cancer Research and Treatment
  • Colorectal Cancer Surgical Treatments
  • Phytoestrogen effects and research

Inje University Haeundae Paik Hospital
2014-2025

Inje University Busan Paik Hospital
2021-2023

Inje University
2005-2019

Busan Medical Center
2013-2016

Yonsei University
2009-2012

To compare outcomes at a 5-year median follow-up among different partial nephrectomy (PN) approaches: robot-assisted (RAPN), laparoscopic (LPN) and open (OPN).We retrospectively analysed 1 308 patients who underwent PN (RAPN, n = 380; LPN, 206; OPN, 722) between 2006 2012 one of four academic centres. We performed 1:1:1 propensity-score-matching adjustment based on confounding variables groups, 366 (122 in each group) were included the final analysis. Survival rates using Kaplan-Meier...

10.1111/bju.14250 article EN BJU International 2018-04-12

No AccessJournal of UrologyAdult Urology1 May 2010Initial Experience With 50 Laparoendoscopic Single Site Surgeries Using a Homemade, Port Device at Center Hwang Gyun Jeon, Wooju Jeong, Cheol Kyu Oh, Enrique Ian S. Lorenzo, Won Sik Ham, Koon Ho Rha, and Woong Han JeonHwang Jeon Department Urology, CHA Bundang Medical Center, University, Seongnam, Korea More articles by this author , JeongWooju Jeong Urological Science Institute, Yonsei University College Medicine, Seoul, OhCheol Oh...

10.1016/j.juro.2010.01.023 article EN The Journal of Urology 2010-03-30

Reducing the risk of urethral strictures after transurethral surgery for patients with bladder cancer requires effective strategies. We compared clinical outcomes a novel drug-injectable catheter set (NIUS) hyaluronic acid (HA) those conventional intraurethral HA injection method. This six-center, prospective, randomized, single-blind trial included 192 male aged ≥ 20 years scheduled to undergo surgery. The primary outcome was patient-reported satisfaction. Secondary were pain intensity,...

10.1038/s41598-024-84164-y article EN cc-by-nc-nd Scientific Reports 2025-01-10

Purpose: Laparoscopic partial nephrectomy (LPN) is an alternative treatment modality for small-sized renal tumors. Robot-assisted LPN (RLPN) has also been performed with advantage in repairing the defect after a resection of tumor. We compared perioperative data patients treated who underwent RLPN. Materials and Methods: From September 2006 to April 2008, 26 were 31 Three arms used RLPN; camera was inserted through 12 mm umbilical trocar port. Bulldog clamps clamping hilum. retrospectively...

10.1089/end.2009.0302 article EN Journal of Endourology 2009-08-21

A 62-year-old male patient with prostate cancer and bilateral renal cell carcinoma underwent a simultaneous robot-assisted partial nephrectomy radical prostatectomy.We describe our initial experience of combined operation port strategy allowing reuse ports surgical considerations because prolonged pneumoperitoneum.

10.3349/ymj.2012.53.1.236 article EN cc-by-nc Yonsei Medical Journal 2011-12-19

Retroperitoneal liposarcoma is a rare tumor. The dimension and weight of are variable; those over 20 kg called 'giant liposarcoma'. Herein, we report giant retroperitoneal measuring 45 cm in diameter 25 encasing the entire left kidney adherent to adjacent structures. A 71-year-old woman presented for regular checkup. Image study revealed huge mass probably indicative We performed an organ-preserving surgical removal. pathologic was liposarcoma. At postoperative month 16, follow-up CT locally...

10.1159/000447488 article EN cc-by-nc Case Reports in Oncology 2016-06-27

Prostate-specific antigen (PSA) is used for diagnosing prostate cancer, but does not reflect the characteristics of cancer cells to allow assessment progression. PSA mRNA and circulating tumor (CTCs) could be potential biomarkers. However, relationship between serum levels in CTCs unclear, this study aimed investigate relationship.Healthy donors (HD, n = 9), patients with local non-metastatic stage (n 30), metastatic hormone-sensitive (mHSPC, 10), castration-resistant (mCRPC, 75), were...

10.1016/j.prnil.2022.01.002 article EN cc-by-nc-nd Prostate International 2022-01-10

Objective To evaluate the clinical impact of prostate peripheral zone thickness ( PZT ), based on presumed circle area ratio PCAR ) theory, urinary symptoms in men with lower tract symptoms/benign prostatic hyperplasia LUTS / BPH as a novel parameter. Patients and methods Medical records were obtained from prospective database first‐visit . Age, international symptom score IPSS overactive bladder OABSS maximum flow rate (Q max post‐void residual urine volume PVR assessed. Total TPV...

10.1111/bju.13130 article EN BJU International 2015-03-24

Excellent success rates with short-term outcomes are noted for laparoscopic ureteral reconstruction (LUR) iatrogenic injury. This multi-institutional study assessed the medium-term (>1 year) and compared three surgical techniques of LUR. Patients who underwent LUR at five tertiary hospitals between January 2007 June 2016 were retrospectively analyzed. active abdominopelvic inflammatory disease, history urothelial cancer, tumor recurrence those received adjuvant chemotherapy or radiotherapy...

10.1016/j.asjsur.2021.01.027 article EN cc-by-nc-nd Asian Journal of Surgery 2021-02-18

Recently, patients with urologic malignancies are treated robot-assisted surgery and the expanded role of includes even those two concomitant primary malignancies. In an effort to further reduce port site-related morbidity, laparoendoscopic single-site (RLESS) has been developed. Therefore, we present herein our early experience feasibility simultaneous RLESS partial nephrectomy standard robotrobot- assisted radical prostatectomy (RALP) on 3 synchronous renal masses prostate cancer.

10.3349/ymj.2014.55.2.535 article EN cc-by-nc Yonsei Medical Journal 2014-01-01

We report a case of synchronous rectal and prostate cancer treated successfully with simultaneous da Vinci robotic-assisted low anterior resection the rectum laparoscopic radical prostatectomy to address both cancers.Recently, minimally invasive surgical techniques using robot® system (Intuitive Surgical, Sunnyvale, USA) were introduced as curative modality malignancies. Herein, we an initial robotic for adenocarcinoma sharing considerable number port sites.Simultaneous could be performed...

10.1186/s40064-016-3456-y article EN SpringerPlus 2016-10-12

Purpose: To determine the ability of a novel palpation device to differentiate between benign and malignant tissues kidney bladder by measuring tissue elasticity.Materials Methods: A was developed, mainly composed micromotor, linear position sensor, force transducer, hemisphere tip cylindrical body probe.Motion calibration as well performance validation done.The elasticity both measured using this device.A single investigator performed ex-vivo experiment in twelve kidneys four...

10.3349/ymj.2011.52.5.768 article EN cc-by-nc Yonsei Medical Journal 2011-01-01

Objectives To compare the efficacy and safety of vaporesection without a morcellator, vapoenucleation with morcellator in thulium laser prostatectomy for treatment benign prostatic obstruction. Methods Between M arch 2010 January 2013, 405 patients underwent thulium:yttrium‐aluminium‐garnet prostatectomy. Among these patients, 150 who ( n = 75) or were analyzed propensity matching study. Outcome measures included International Prostate Symptom Score, quality life score, maximum flow rate,...

10.1111/iju.12547 article EN International Journal of Urology 2014-07-14

To investigate the learning curve for robot-assisted laparoscopic radical prostatectomy (RALP) pathologic T2 disease, we examined differences in perioperative outcomes according to time period. Between July 2005 and June 2008, a total of 307 consecutive patients underwent RALP prostate cancer 205 had disease. Patients were grouped into 6-month periods. We collected patient's data including age, body mass index (BMI), prostate-specific antigen (PSA), operation time, estimated blood loss,...

10.4111/kju.2010.51.1.30 article EN cc-by-nc Korean journal of urology 2010-01-01

Purpose:We report herein 119 patients with pheochromocytoma at our institute over the last 23 years.Materials and Methods: Between 1986 2009, were diagnosed institute.We reviewed medical records of these patients.Results: Of patients, 45 male 74 female, mean age was 43.83 ± 13.49 years.Forty-three (36.1%) incidentally, 8 (6.7%) found to have familial pheochromocytoma.The dimension tumors 5.89 3.18 cm. 4 had bilateral tumors; three 1 patient malignant pheochromocytoma.A total eight...

10.3349/ymj.2011.52.1.45 article EN cc-by-nc Yonsei Medical Journal 2010-12-10

To identify incidence and risk factors of recurrence after discontinuation successful antimuscarinic therapy in patients with overactive bladder (OAB).This was a prospective, multicenter trial. Patients who had agents for more than 12 weeks showed response were enrolled. Successful defined as answering 'benefit' patient perception treatment benefit answer lesser 3 points patient's condition (PPBC). The enrolled discontinued the antimuscarinics, we evaluated their PPBC OAB symptom score...

10.4111/icu.2017.58.1.42 article EN cc-by-nc Investigative and Clinical Urology 2017-01-01

Sunitinib is a first-line treatment for metastatic renal cell carcinoma (mRCC). Little known about the predictive factors of sunitinib-induced dose-limiting toxicity (DLT) in Asian populations. We investigated whether body composition predicts DLT. retrospectively reviewed sunitinib-treated Korean patients with clear mRCC from eight institutions. Body was measured using computed tomography. DLT defined as any adverse event leading to dose reduction or discontinuation. Univariate analysis...

10.3390/cancers12123602 article EN Cancers 2020-12-02
Coming Soon ...